Record Half-Year Revenue
Total revenue of $23.9 million was a record half-year result, up 19% compared to the previous corresponding period.
Significant Growth in Clinical Trials Revenue
Clinical trials revenue increased by 27% compared to the previous corresponding period.
Profit Before Tax Surge
Profit before tax of $5.2 million was up 150% on the previous corresponding period.
Positive Operating Cash Flow
Operating cash flow of $5 million, resulting in a closing cash balance of $34.2 million.
Strong Sales Contracts Execution
Sales contracts executed totaled $20.3 million, up 86% on the first half of the previous year.
Medidata Partnership Success
First joint award achieved with Medidata, with an established strong initial pipeline of opportunities from 28 different pharma sponsors.